Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MANNKIND CORPMNKD · Entity 4792 | Director | September 25, 2026 | September 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MANNKIND CORP
Report date September 25, 2026 · Filed September 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 Par ValueSEC Table I · non-derivative | Direct | 713,258 |
Reported balance
After 2026-09-25 transaction · row 1
1 source rowRow 1 · 2026-09-25 · Sale · Disposed 39,051 · Balance 713,258 F1: Transaction occurred pursuant to Rule 10B5-1 Plan established December 2, 2025. F2: The weighted average sales price of the reported transaction was $3.29 based on a range of prices between $3.20 and $3.36. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction occurred pursuant to Rule 10B5-1 Plan established December 2, 2025.
F2: The weighted average sales price of the reported transaction was $3.29 based on a range of prices between $3.20 and $3.36. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 24, 2023 Filed May 25, 2023 01:00 UTC | MANNKIND CORP MNKD · Entity 4792 | SaleCommon Stock, $.01 Par Value | 47,810 | $4.68 | $223,511.75 |
DisclosureSEC source: 0001209191-23-032034 · doc4.xml · nonDerivative · entry 3 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 838,324 F3 · kind: Transaction occurred pursuant to Rule 10B5-1 Plan. Read SEC document |
| May 22, 2023 Filed May 25, 2023 01:00 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 227,405 | $4.79 | $1,089,269.95 |
DisclosureSEC source: 0001209191-23-032034 · doc4.xml · nonDerivative · entry 2 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 886,134 F2 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| May 22, 2023 Filed May 25, 2023 01:00 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantCommon Stock, $.01 Par Value | 400,000 | $4.79 | $1,916,000.00 |
DisclosureSEC source: 0001209191-23-032034 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,113,539 F1 · kind: A previously reported restricted stock unit award granted on August 27, 2020 vested on May 22, 2023 upon the achievement of performance objectives established by MannKind's compensation committee at the time of the approval of the award. Specifically, (i) the closing price of MannKind's common stock on May 22, 2023 was not less than the closing price on August 27, 2020 and (ii) the percentile ranking of MannKind's total shareholder return (TSR) over the period from August 27, 2020 to May 22, 2023 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period was greater than the 90th percentile. As a result, the performance objective was achieved at 300% of target, resulting in a total share delivery of 600,000 shares. The acquisition of 200,000 shares pursuant to the restricted stock award was reported in Table I of the Form 4 filed by the Reporting Person on August 31, 2020. Read SEC document |
| May 22, 2023 Filed May 31, 2023 01:00 UTC Amendment | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 281,267 | $4.79 | $1,347,268.93 |
DisclosureSEC source: 0001209191-23-033054 · doc4a.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 876,462 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Previously reported 227,405 shares were withheld. This Form 4A reports the final settlement to satisfy the tax liability with 281,267 shares withheld instead. F1 · shares: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Previously reported 227,405 shares were withheld. This Form 4A reports the final settlement to satisfy the tax liability with 281,267 shares withheld instead. Read SEC document |
| May 18, 2023 Filed May 20, 2023 01:00 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 5,972 | $4.56 | $27,232.32 |
DisclosureSEC source: 0001209191-23-031285 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 713,539 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| May 15, 2023 Filed May 15, 2023 21:00 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantCommon Stock,$.01 par value | 11,820 | $4.23 | $49,998.60 |
DisclosureSEC source: 0001209191-23-029519 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 719,511 F1 · kind: The securities were purchased through the Issuer's Market Price Stock Purchase Plan. The purchase was approved by the Company's Board of Directors on May 13, 2023. Read SEC document |
| May 10, 2023 Filed May 13, 2023 01:00 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 7,781 | $4.40 | $34,236.40 |
DisclosureSEC source: 0001209191-23-029237 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 707,691 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| August 27, 2022 Filed Aug 30, 2022 01:00 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 14,178 | $3.73 | $52,883.94 |
DisclosureSEC source: 0001209191-22-047945 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 714,819 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| July 31, 2022 Filed Aug 1, 2022 10:00 UTC | MANNKIND CORP MNKD · Entity 4792 | PurchaseCommon Stock, $0.01 Par Value | 791 | $2.93 | $2,317.63 |
DisclosureSEC source: 0001209191-22-043573 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 728,997 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan effective July 31, 2022. Read SEC document |
| July 31, 2022 Filed Aug 25, 2022 01:01 UTC Amendment | MANNKIND CORP MNKD · Entity 4792 | GrantCommon Stock, $0.01 Par Value | 791 | $2.93 | $2,317.63 |
DisclosureSEC source: 0001209191-22-047430 · doc4a.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 728,997 F1 · kind: This Form 4 is being amended to correct the transaction code. The securities were purchased through the Company's Employee Stock Purchase Plan effective July 31, 2022. Read SEC document |
| May 18, 2022 Filed May 21, 2022 00:00 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 5,972 | $3.19 | $19,050.68 |
DisclosureSEC source: 0001209191-22-031200 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 728,206 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| May 10, 2022 Filed May 13, 2022 00:00 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit | 110,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028671 · doc4.xml · nonDerivative · entry 2 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 734,178 F3 · shares: The restricted stock unit will vest on May 10, 2025 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on May 10, 2022. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from May 10, 2022 until May 10, 2025 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| May 10, 2022 Filed May 13, 2022 00:00 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028671 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 624,178 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 22:00 UTC | MANNKIND CORP MNKD · Entity 4792 | PurchaseCommon Stock, $0.01 Par Value | 711 | $3.17 | $2,253.87 |
DisclosureSEC source: 0001209191-22-006418 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 534,178 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan effective January 31, 2022. Read SEC document |
| January 31, 2022 Filed Aug 25, 2022 01:00 UTC Amendment | MANNKIND CORP MNKD · Entity 4792 | GrantCommon Stock, $0.01 Par Value | 711 | $3.17 | $2,253.87 |
DisclosureSEC source: 0001209191-22-047427 · doc4a.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 534,178 F1 · kind: This Form 4 is being amended to correct the transaction code. The securities were purchased through the Company's Employee Stock Purchase Plan effective January 31, 2022. Read SEC document |
| August 27, 2021 Filed Aug 28, 2021 01:00 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 14,177 | $4.91 | $69,609.07 |
DisclosureSEC source: 0001209191-21-053765 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 533,467 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| July 30, 2021 Filed Aug 3, 2021 00:00 UTC | MANNKIND CORP MNKD · Entity 4792 | PurchaseCommon Stock, $0.01 Par Value | 748 | $2.99 | $2,236.52 |
DisclosureSEC source: 0001209191-21-049138 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 547,644 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan effective July 31, 2021. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:00 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit | 79,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034454 · doc4.xml · nonDerivative · entry 2 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 546,896 F3 · shares: The restricted stock unit will vest on May 17, 2024 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on May 17, 2021. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from May 18, 2021 until May 17, 2024 relative to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| May 18, 2021 Filed May 20, 2021 21:00 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit | 69,074 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034454 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 467,896 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date. Read SEC document |
| January 31, 2021 Filed Feb 2, 2021 23:18 UTC | MANNKIND CORP MNKD · Entity 4792 | PurchaseCommon Stock, $0.01 Par Value | 1,557 | $1.33 | $2,070.81 |
DisclosureSEC source: 0001209191-21-006886 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,822 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan effective January 31, 2021. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 23:06 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048845 · doc4.xml · nonDerivative · entry 2 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 397,265 F3 · shares: The restricted stock unit will vest on May 22, 2023 provided that the closing price of MannKind common stock on such vesting date is not less than the closing price on August 27, 2020. The number of shares delivered on the vesting date, as a percentage of the target specified in Box 4 above, is determined by the percentile ranking of MannKind total shareholder return (TSR) over the period from August 27, 2020 until May 22, 2023 related to the TSR of the Russell 3000 Pharmaceutical & Biotechnology Index over the same period, as follows: less than 25th percentile=0% of target, 25th percentile=50% of target, 50th percentile=100% of target, 75th percentile=200% percent of target, 90th percentile or higher=300% maximum. Payout values will be interpolated between the percentile rankings above. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 23:06 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit | 164,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-048845 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,265 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Acquired pursuant to a Restricted Stock Unit Award: 25% vest on each year annivesary of the vesting determination date and 25% each anniversary thereafter; shares shall fully vest on the fourth year anniversary of the vesting determination date. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 22:45 UTC | MANNKIND CORP MNKD · Entity 4792 | PurchaseCommon Stock, $0.01 Par Value | 1,522 | $1.25 | $1,902.50 |
DisclosureSEC source: 0001209191-20-044840 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,265 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan on July 31, 2020. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 11:00 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantEmployee Stock Option (right to buy) · Derivative | 45,025 | $1.47 Strike: $1.47 | $66,186.75 |
DisclosureSEC source: 0001209191-20-013629 · doc4.xml · derivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,025 Underlying: Stock Options · 45,025 shares Expires 2027-08-24 F1 · kind: On August 24, 2017, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On February 25, 2020, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
| February 20, 2020 Filed Feb 21, 2020 22:53 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 16,461 | $1.51 | $24,856.11 |
DisclosureSEC source: 0001209191-20-011688 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,743 F1 · shares: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 02:14 UTC | MANNKIND CORP MNKD · Entity 4792 | PurchaseCommon Stock, $0.01 Par Value | 2,168 | $0.95 | $2,059.60 |
DisclosureSEC source: 0001209191-20-006171 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,204 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan on January 31, 2020. Read SEC document |
| July 31, 2019 Filed Aug 1, 2019 00:40 UTC | MANNKIND CORP MNKD · Entity 4792 | PurchaseCommon Stock, $0.01 Par Value | 2,139 | $0.95 | $2,032.05 |
DisclosureSEC source: 0001209191-19-043923 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,036 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan on July 31, 2019. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:23 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantEmployee Stock Option (right to buy) · Derivative | 234,000 | $1.32 Strike: $1.32 | $308,880.00 |
DisclosureSEC source: 0001209191-19-030373 · doc4.xml · derivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,000 Underlying: Stock Options · 234,000 shares Expires 2029-05-14 F1 · kind: Annual Equity Award: 25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. Read SEC document |
| February 20, 2019 Filed Feb 25, 2019 11:03 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit | 40,268 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-012812 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,897 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Restricted stock units shall vest and be delivered on February 20, 2020. Read SEC document |
| January 31, 2019 Filed Jan 31, 2019 23:19 UTC | MANNKIND CORP MNKD · Entity 4792 | PurchaseCommon Stock, $0.01 Par Value | 1,860 | $1.07 | $1,990.20 |
DisclosureSEC source: 0001209191-19-006274 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,620 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan on January 31, 2019. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 23:17 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantEmployee Stock Option (right to buy) · Derivative | 45,025 | $1.47 Strike: $1.47 | $66,186.75 |
DisclosureSEC source: 0001209191-18-045600 · doc4.xml · derivative · entry 2 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,025 Underlying: Stock Options · 45,025 shares Expires 2027-08-24 F2 · kind: On August 24, 2017, the reporting person was granted an option that vests upon the achievement of certain defined performance milestones. On August 2, 2018, one of the defined performance milestones was met, resulting in the partial vesting of the option. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 23:17 UTC | MANNKIND CORP MNKD · Entity 4792 | PurchaseCommon Stock, $0.01 Par Value | 1,760 | $1.31 | $2,305.60 |
DisclosureSEC source: 0001209191-18-045600 · doc4.xml · nonDerivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,760 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan on August 2, 2018, Read SEC document |
| May 16, 2018 Filed May 18, 2018 14:07 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantEmployee Stock Option (right to buy) · Derivative | 214,000 | $1.91 Strike: $1.91 | $408,740.00 |
DisclosureSEC source: 0001209191-18-031281 · doc4.xml · derivative · entry 1 Binder Steven B. · CIK 0001712601 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,000 Underlying: Stock Options · 214,000 shares Expires 2028-05-16 F1 · kind: 25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.